US Patent No. 8,962,267

Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy
Mar 09, 2015

Pamgene and Stichting Het Nederlands Kanker Instituut have been awarded US Patent No. 8,962,267, "Method for predicting the response of non-small cell lung cancer patients to targeted pharmacotherapy."

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
04
Sponsored by
Agilent

This webinar will discuss the use of new software tools to support the diagnosis of CTFR-related disorders using next-generation sequencing.